Hepatitis B Control

(1)

Hepatitis B Control

Country Profiles 2013

(2)

(3)

Hepatitis B Control

Country Profiles 2013

(4)

All rights reserved. Publications of the World Health Organization are available on the WHO web site (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax:

+41 22 791 4857;

email: bookorders@who.int).

Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution– should be addressed to WHO Press through the WHO web site (www.who.int/about/licensing/copyright_form/en/index.html). For WHO Western Pacific Regional Publications, request for permission to reproduce should be addressed to Publications Office, World Health Organization, Regional Office for the Western Pacific, P.O. Box 2932, 1000, Manila, Philippines, fax: +632 521 1036, email:

publications@wpro.who.int

The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.

The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.

All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication.

However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages

(5)

Regional Progress: Hepatitis B Vaccination Coverage, 1990 – 2013 1 Regional Progress: Status of the 2013 Hepatitis B Control Milestone 2

Country Profiles

American Samoa 3

Australia 4

BruneI Darussalam 5

Cambodia 6

China 7

Hong Kong SAR (China) 8

Macao SAR (China) 9

Cook Islands 10

Fiji 11

French Polynesia 12

Guam 13

Japan 14

Kiribati 15

Lao People’s Democratic Republic 16

Malaysia 17

Marshall Islands 18

Federated States of Micronesia 19

Mongolia 20

Nauru 21

New Caledonia 22

New Zealand 23

Niue 24

Northern Mariana Islands 25

Palau 26

Papua New Guinea 27

Philippines 28

Republic of Korea 29

Samoa 30

Singapore 31

Solomon Islands 32

Tokelau 33

Tonga 34

Tuvalu 35

Vanuatu 36

Viet Nam 37

Wallis and Futuna 38

(6)

Demographics

COUNTRY

Race ethnicity Hepatitis B vaccine

Total Population (2012) Births (2012)

Surviving infants (2012) Urban Population (2012)

Aasd HepB3 Introduced Nationwide

HepB Birth Dose Introduced Current schedule

HepB3 type

HepB3 manufacturer HepB BD manufacturer

2012 Neonatal deliveries 2012 Reported hepatitis B vaccination coverage 2012 Percent of districts by coverage categories^*

Coverage surveys

Survey Geographic Ages Sample HepB BD HepB3 DTP3 Reference/Notes

Year Location Enrolled Size % % %

Hepatitis B prevalance in children

Survey Geographic Ages Sampling Sample HBsAG Prevalence Reference/Notes

Year Location Enrolled Base Size (95% CI)

WHO verification

Status of Verifying Prevalence Targets Verification Started:

Decision:

(7)

Demographics

COUNTRY

Race ethnicity Hepatitis B vaccine

Total Population (2012) Births (2012)

Surviving infants (2012) Urban Population (2012)

Aasd HepB3 Introduced Nationwide

HepB Birth Dose Introduced Current schedule

HepB3 type

HepB3 manufacturer HepB BD manufacturer

2012 Neonatal deliveries 2012 Reported hepatitis B vaccination coverage 2012 Percent of districts by coverage categories^*

Coverage surveys

Survey Geographic Ages Sample HepB BD HepB3 DTP3 Reference/Notes

Year Location Enrolled Size % % %

Hepatitis B prevalance in children

Survey Geographic Ages Sampling Sample HBsAG Prevalence Reference/Notes

Year Location Enrolled Base Size (95% CI)

WHO verification

Status of Verifying Prevalence Targets Verification Started:

NR Decision:

(8)

0 20 40 60 80 100

2009 2010 2011 2012 2013

Vaccination Coverage (%)

Timely HepB BD HepB3 Any HepB BD

0 20 40 60 80 100

<50% 50%-79% 80%-89% 90%-94% > 94%

% Districts 2013

HepB3 Timely HepB BD

Demographics

AMERICAN SAMOA

Hepatitis B vaccine

Total Population (2013) 55 165

Births (2013) 1 287

Surviving infants (2013) 1 278

Urban Population (2013) 93%

HepB3 introduced nationwide 1986–1987 HepB birth dose introduced not reported

Current schedule NR

HepB3 type Monovalent

2012 Neonatal deliveries 2013 Reported hepatitis B vaccination coverage 2013 Districts by coverage categories*

Vaccination coverage surveys

Survey Location Ages Sample HepB BD HepB3 DTP3 Reference/Notes

year enrolled size % % %

1990 National 3–4 years 95 not reported 82% NR Mahoney Pac Hth Dialog 1996

1995 National 7–8 years 432 75% 91% NR Bialek ISVHLD P351 2006

1996 National 7–8 years 435 not reported 87% NR Mahoney Pac Hth Dialog 1996

Hepatitis B serological surveys

Survey Location Ages Sampling Sample HBsAG prevalence Reference/Notes

year enrolled base size (95% CI)

1991 T utuila 3–4 years Community based 93 2.2% Mahoney JID 2009

1995 Nationwide 7–8 years Community based 432 0.5% Bialek ISVHLD P351 2006

2011 Nationwide 6 years School based 562 0.20% PRELIMINARY DATA

WHO verification

Status of verifying prevalence targets Verification started: 27 February 2013 Decision: <1% in children Decision date: October 2014 99.0%

Health Facility Home with SBA Home with no SBA Unknown

(9)

Demographics Hepatitis B vaccine

AUSTRALIA

Total population (2013) 23 342 553

Births (2013) 308 051

Urban population (2013) 89%

HepB3 introduced nationwide 2000

HepB birth dose introduced 2000

Current schedule 0, 2 months, 4 months, 6 months

HepB3 type DTP-Hib-HepB-IPV

2007 National 12 months 280874 not reported 94% 92% From National Health Insurance covering 99% of population

2002 Nationwide 1–9 years Hospital based 249 0.4% (0.0% – 2.2%) Gidding Vaccine 2007

WHO verification

Status of verifying prevalence targets Verification started: June 2012 Decision: <1% in children Decision date: December 2012 99.1%

0.9%

Health Facility Home with SBA Home with no SBA

Unknown 0

20 40 60 80 100

2009 2010 2011 2012 2013

0 20 40 60 80 100

<50% 50%-79% 80%-89% 90%-94% > 94%

% Districts 2013

(10)

Demographics

BRUNEI

DARUSSALAM

Hepatitis B vaccine

Total population (2013) 417 784

Births (2013) 6493

Surviving infants (2013) 6536

2011 National 8–9 years School based 4513 not reported MoH 2011 prelim data

WHO verification

Status of verifying prevalence targets Verification started: pending Decision: n.a.

Decision date: n.a.

99.8%

0.1%

Unknown 0

20 40 60 80 100

2009 2010 2011 2012 2013

0 20 40 60 80 100

<50% 50%-79% 80%-89% 90%-94% > 94%

% Districts 2013

(11)

CAMBODIA

Births (2013) 388 795

Current schedule 0, 6 weeks, 10 weeks,14 weeks

HepB3 type DTP-Hib-HepB

2005 National 12–24 months 1517 not reported not reported 78% DHS Survey

2010 National 12–24 months 1614 73% 84% not reported DHS Survey: birth dose by 12M

2001 Kg Chhnang 9–17 months Hospital based 900 2.7% Report MoH/PATH/AIHI

2006 Nationwide 5 years Community based 1558 3.5% (2.4% – 4.8%) Soeung AMTH 2009 2011 Urban, Rural, Remote 4–5 years Community based 2429 0.3%, 1.4%, 3.4% PRELIMINARY DATA

WHO verification

Decision date: n.a.

0 20 40 60 80 100

2009 2010 2011 2012 2013

0 20 40 60 80 100

<50% 50%-79% 80%-89% 90%-94% > 94%

% Districts 2013

54.0%

29.0%

(12)

Demographics

CHINA

Hepatitis B vaccine Total population (2013) 1 385 566 537

Births (2013) 18 440 329

Surviving infants (2013) 18 224 613

Current schedule 0, 1 months, 6 months

2006 National 1 year 3636 93% 83% not reported Liang JID 2009; 2005 birth cohort

2006 Nationwide 1–4 years Community based 16376 1.0% (0.8% – 1.2%) Liang Vaccine 2009 2006 Nationwide 5 years Community based 2215 1.1% (0.4% – 1.8%) Liang JID 2009 2006 Nationwide 6 years Community based 2356 0.9% (0.4% – 1.5%) Liang JID 2009

WHO verification

Status of verifying prevalence targets Verification started: February 2012 Decision: <1% in children Decision date: June 2012 96.3%

3.7%

0 20 40 60 80 100

2009 2010 2011 2012 2013

0 20 40 60 80 100

<50% 50%-79% 80%-89% 90%-94% > 94%

% Districts 2013

(13)

Demographics

HONG KONG SAR (CHINA)

Hepatitis B vaccine

Births (2013) 67 665

2009 National 2–5 years 6248 not reported ≥99.5% >99.8% MoH HOK 2011

2006 Nationwide 1–4 years Laboratory based 196 1% MoH HOK 2011

2009 Nationwide 12–15 years School based 1913 0.8% (0.4% – 1.2%) MoH HOK 2011

WHO verification

Status of verifying prevalence targets Verification started: February 2011 Decision: <1% in children Decision date: July 2011 100.0%

0 20 40 60 80 100

2009 2010 2011 2012 2013

0 20 40 60 80 100

<50% 50%-79% 80%-89% 90%-94% > 94%

% Districts 2013

(14)

Demographics

MACAO SAR (CHINA)

Hepatitis B vaccine

Births (2013) 5743

2003 Nationwide 6–9 years School based 437 0% (0% – 0.7%) MoH MAC 2008

WHO verification

Status of verifying prevalence targets Verification started: April 2008 Decision: <1% in children Decision date: August 2008 100.0%

Unknown 0

20 40 60 80 100

2009 2010 2011 2012 2013

0 20 40 60 80 100

<50% 50%-79% 80%-89% 90%-94% > 94%

% Districts 2013

(15)

COOK ISLANDS

Births (2013) 260

HepB birth dose introduced not reported Current schedule 0, 6 weeks, 3 months, 5 months

2012 7 of 11 islands 6 years School based 265 0% PRELIMINARY DATA

WHO verification

Status of verifying prevalence targets Verification started: January 2013 Decision: NR

Decision date: NR

99.6%

Unknown ₀

20 40 60 80 100

2009 2010 2011 2012 2013

0 20 40 60 80 100

<50% 50%-79% 80%-89% 90%-94% > 94%

% Districts 2013

(16)

Demographics

FIJI

Hepatitis B vaccine

Births (2013) 17 977

2012 Neonatal deliveries 2013 Reported hepatitis B vaccination coverage Districts by coverage categories*

2008 not reported not reported 439 86% 99% not reported Confirm data with country

1998 Large T owns 12–24 months Hospital based 285 0.7% Wilson Vaccine 2000

2008 Sub-national 6 months–5 years Community based 428 0% WHO:RS/2009/GE/23(JPN)

WHO verification

Decision date: n.a.

99.8%

0.2%

Unknown ⁰

20 40 60 80 100

2009 2010 2011 2012 2013

0 20 40 60 80 100

<50% 50%-79% 80%-89% 90%-94% > 94%

% Districts 2013

(17)

Demographics

FRENCH POLYNESIA

Hepatitis B vaccine

Births (2013) 4541

HepB birth dose introduced not reported Current schedule 0, 1 months, 6 months

1988 Austral Island 0–11 months Community based 957 2.1% B Trans R Soc Trop 1990

WHO verification

Decision date: n.a.

99.0%

0 20 40 60 80 100

2009 2010 2011 2012 2013

0 20 40 60 80 100

<50% 50%-79% 80%-89% 90%-94% > 94%

% Districts 2013

(18)

Demographics

GUAM

Hepatitis B vaccine

Births (2013) 2879

HepB3 introduced nationwide 1988–1989 HepB birth dose introduced not reported Current schedule 0, 1 months, 6 months, 19 years

WHO verification

Decision date: n.a.

87.2%

12.2%

Unknown ₀

20 40 60 80 100

2009 2010 2011 2012 2013

0 20 40 60 80 100

<50% 50%-79% 80%-89% 90%-94% > 94%

% Districts 2013

(19)

JAPAN

Total Population (2013) 127 143 577

Births (2013) 1 061 717

HepB3 introduced nationwide not reported HepB birth dose introduced not reported

Current schedule if HBsAg+ mother

1989 Okinawa 1–4 years School based 1529 0.1% Hayashi Int J Epi 1990

1995–1996 Nationwide 16–19 years Blood Donors 107879 0.4% (0.4% – 0.5%) Furusyo AMTM 1998 1995–2000 Nationwide 16–19 years Blood Donors 582415 0.23% (0.22% – 0.24%) Tanaka Intervirol 2004

WHO verification

Decision date: n.a.

99.8%

0.1%

Unknown 0

20 40 60 80 100

2009 2010 2011 2012 2013

0 20 40 60 80 100

<50% 50%-79% 80%-89% 90%-94% > 94%

% Districts 2013

(20)

Demographics

KIRIBATI

Hepatitis B vaccine

Births (2013) 3200

Neonatal deliveries Reported hepatitis B vaccination coverage Districts by coverage categories*

1998 Large Towns 12–24 months Hospital based 156 3.8% Wilson Vaccine 2000

WHO verification

Decision date: n.a.

81.9%

1.8%

Unknown ⁰

20 40 60 80 100

2009 2010 2011 2012 2013

0 20 40 60 80 100

<50% 50%-79% 80%-89% 90%-94% > 94%

% Districts 2013

(21)

Demographics

LAO PEOPLE’S DEMOCRATIC REPUBLIC

Hepatitis B vaccine

Births (2013) 181 078

HepB birth dose introduced ~ 2005

2006 National 12 months 828 not reported not reported 32% MICS; 41.3% HepB3 by 23M

2011 National 5–9 years Community based 1008 1.5% PRELIMINARY DATA

WHO verification

Decision date: n.a.

12.8%

81.5%

Unknown ⁰

20 40 60 80 100

2009 2010 2011 2012 2013

0 20 40 60 80 100

<50% 50%-79% 80%-89% 90%-94% > 94%

% Districts 2013

(22)

Demographics

MALAYSIA

Hepatitis B vaccine Total Population (2013) 29 706 965

Births (2013) 524 815

1997–2007 Nationwide 6–9 years School based 193717 0.4% MoH Malaysia 2011

2009 Nationwide 9 years School based 2938 0.2% (0% – 0.3%) MoH Malaysia 2011

2009 Nationwide 10 years School based 3265 0.4% (0.2% – 0.6%) MoH Malaysia 2011

WHO verification

Status of verifying prevalence targets Verification started: March 2011 Decision: <1% in children Decision date: July 2011 98.1%

1.4%

Unknown ⁰

20 40 60 80 100

2009 2010 2011 2012 2013

0 20 40 60 80 100

<50% 50%-79% 80%-89% 90%-94% > 94%

% Districts 2013

(23)

Demographics

MARSHALL ISLANDS

Hepatitis B vaccine

Births (2012) 1468

HepB3 introduced nationwide 1990s

HepB3 type DTP-HepB-IPV

2007 Majuro, Ebeye 5–9 years 331 49% 93% not reported Bialek Ped Infect Dis 2010

2007 Majuro, Ebeye 5–9 years School based 331 1.8% (0.4% – 3.3%) Bialek PID 2010

WHO verification

Decision date: n.a.

97.0%

1.0%

Unknown ₀

20 40 60 80 100

2009 2010 2011 2012 2013

0 20 40 60 80 100

<50% 50%-79% 80%-89% 90%-94% > 94%

% Districts 2013

(24)

Demographics

FEDERATED STATES OF MICRONESIA

Hepatitis B vaccine

Total Population (20123 103 549

Births (2013) 2453

HepB3 introduced nationwide not reported HepB birth dose introduced not reported Current schedule 0, 2 months, 4 months, 6 months

1989 National 2 years 16391 not reported 84% not reported Manea PH Reports 1992

1992 Chuuk 2 years 544 not reported 40% not reported Mahoney Pac Hth Dialog 1996

1994 Pohnpei 3–4 years 364 not reported 82% not reported Mahoney Pac Hth Dialog 1996

2005 Chuuk 2–6 years Hospital based 362 2.5% Bialek PID 2010

WHO verification

Decision date: n.a.

80.0%

Unknown ₀

20 40 60 80 100

2009 2010 2011 2012 2013

0 20 40 60 80 100

<50% 50%-79% 80%-89% 90%-94% > 94%

% Districts 2013

(25)

MONGOLIA

Births (2013) 64 280

HepB birth dose introduced not reported Current schedule 0, 2 months, 3 months, 4 months

1999 Urban Area 2 years 127 not reported 94% not reported Edstam Prev Med 2002

1999 Rural 2 years 148 not reported 76% not reported Edstam Prev Med 2002

2004 National 8 years 1145 65% 60% not reported Davaalkham J Epid 2007

2004 Nationwide 7–12 years School based 1145 5.2% Davaalkham PI 2007

2009 Nationwide 4 years Community based 5894 0.34% MoH Mongolia 2011

WHO verification

Status of verifying prevalence targets Verification started: April 2012 Decision: <1% in children Decision date: July 2012 99.5%

0.2%

Unknown ₀

20 40 60 80 100

2009 2010 2011 2012 2013

0 20 40 60 80 100

<50% 50%-79% 80%-89% 90%-94% > 94%

% Districts 2013

(26)

Demographics

NAURU

Hepatitis B vaccine

Births (2013) 365

HepB birth dose introduced not reported

Current schedule NR

WHO verification

Decision date: n.a.

97.4%

0 20 40 60 80 100

2009 2010 2011 2012 2013

0 20 40 60 80 100

<50% 50%-79% 80%-89% 90%-94% > 94%

% Districts 2013

(27)

NEW CALEDONIA

Births (2013) 4004

HepB birth dose introduced 1998 (for HBsAg+ moms) Current schedule 0, 1 months, 6 months

WHO verification

Decision date: n.a.

87.6%

8.0%

Unknown ₀

20 40 60 80 100

2009 2010 2011 2012 2013

0 20 40 60 80 100

<50% 50%-79% 80%-89% 90%-94% > 94%

% Districts 2013

(28)

Demographics

NEW ZEALAND

Hepatitis B vaccine

Births (2013) 62 316

HepB birth dose introduced not reported Current schedule 6 weeks, 3 months, 5 months

2005 National 12 months 1563 72% 82% 85% MoH; 87% HepB3 by 2Y

2009 North Islands 6 years Health facility 466 0.2% (0.0% – 1.2%) Weir R. MoH NEZ 2009

WHO verification

Status of verifying prevalence targets Verification started: April 2012 Decision: <1% in children Decision date: September 2012 95.3%

0 20 40 60 80 100

2009 2010 2011 2012 2013

0 20 40 60 80 100

<50% 50%-79% 80%-89% 90%-94% > 94%

% Districts 2013

(29)

NIUE

Total Population (2013) 1344

Births (2013) 25

HepB3 introduced nationwide not reported HepB birth dose introduced not reported Current schedule 0, 6 weeks, 3 months, 5 months

WHO verification

Decision date: n.a.

100.0%

Unknown 0

20 40 60 80 100

2009 2010 2011 2012 2013

0 20 40 60 80 100

<50% 50%-79% 80%-89% 90%-94% > 94%

% Districts 2013

(30)

Demographics

NORTHERN

MARIANA ISLANDS

Hepatitis B vaccine

Births (2013) 1061

Current schedule 0, 6 weeks, 6 months

1995 National 3–4 years 200 not reported 94% not reported Mahoney Pac Hth Dialog 1996

2005 National 19–35 months 295 100% 94% not reported not reported

1994 Saipan 3–4 years Health facility 200 0.5% Durand Pac Hlth Dial 1996

WHO verification

Decision date: n.a.

100.0%

Unknown 0

20 40 60 80 100

2009 2010 2011 2012 2013

0 20 40 60 80 100

<50% 50%-79% 80%-89% 90%-94% > 94%

% Districts 2013

(31)

PALAU

Births (2013) 229

2003 National 10–11 years 192 100% 85% not reported Bialek ISVHLD P351 2006

2003 Nationwide 10–11 years Community based 192 0% Bialek ISVHLD P351 2006

WHO verification

Status of verifying prevalence targets Verification started: January 2013 Decision: <1% in children Decision date: May 2013 100.0%

Unknown 0

20 40 60 80 100

2009 2010 2011 2012 2013

0 20 40 60 80 100

<50% 50%-79% 80%-89% 90%-94% > 94%

% Districts 2013

(32)

Demographics

PAPUA NEW GUINEA

Hepatitis B vaccine

Births (2013) 211 555

1989–1990 Port Moresby 3–5 months Hospital based 31 13% Nemba A TPaed. 1993

WHO verification

Decision date: n.a.

0 20 40 60 80 100

2009 2010 2011 2012 2013

0 20 40 60 80 100

<50% 50%-79% 80%-89% 90%-94% > 94%

% Districts 2013

40.0%

60.0%

(33)

PHILIPPINES

Births (2013) 2 403 943

Current schedule 0, 6 weeks, 10 weeks, 14 weeks

2003 National 12–24 months 1348 not reported NR 79 DHS Survey

2008 National 12–24 months 1286 not reported 80.3 not reported DHS Survey

WHO verification

Decision date: n.a.

0 20 40 60 80 100

2009 2010 2011 2012 2013

0 20 40 60 80 100

<50% 50%-79% 80%-89% 90%-94% > 94%

% Districts 2013

44.0%

37.8%

(34)

Demographics

REPUBLIC OF KOREA

Hepatitis B vaccine Total Population (2013) 49 262 698

Births (2013) 472 386

Current schedule 0, 1 month, 6 months

2008 National 0–6 years 1026 100% 93% 94.7% CDC Korea; provided during 2012 TAG

2011 National 0–3 years 7040 99% 98% 93.4% CDC Korea; provided during 2012 TAG

2005 Nationwide 10–14 years Community based 594 0.2% (0.0% – 0.6%) CDC Korea 2008 2007 Nationwide 4–6 years Hospital based 2920 0.2% (0.0% – 0.4%) CDC Korea 2008

WHO verification

Status of verifying prevalence targets Verification started: January 2008 Decision: <1% in children Decision date: June 2008 99.9%

Unknown ₀

20 40 60 80 100

2009 2010 2011 2012 2013

0 20 40 60 80 100

<50% 50%-79% 80%-89% 90%-94% > 94%

% Districts 2013

(35)

SAMOA

Births (2013) 4986

HepB3 introduced nationwide not reported HepB birth dose introduced not reported

Current schedule not reported

HepB3 type not reported

2009 National 12–24 months 321 70% not reported not reported DHS Survey

WHO verification

Decision date: n.a.

81.0%

19.0%

Unknown 0

20 40 60 80 100

2009 2010 2011 2012 2013

0 20 40 60 80 100

<50% 50%-79% 80%-89% 90%-94% > 94%

% Districts 2013

(36)

Demographics

SINGAPORE

Hepatitis B vaccine

Births (2013) 53 587

Current schedule not reported

2007 National 2 years 31778 not reported 94–96% 97% not reported

1998–1999 National 0–4 years not reported 229 0% Epi News Bull SNG 2000

WHO verification

Decision date: n.a.

99.7%

0.3%

Unknown ₀

20 40 60 80 100

2009 2010 2011 2012 2013

0 20 40 60 80 100

<50% 50%-79% 80%-89% 90%-94% > 94%

% Districts 2013

(37)

Demographics

SOLOMON ISLANDS

Hepatitis B vaccine

Births (2013) 17 293

1999 Guadalcanal Islands 0–9 years Hospital based 115 13% Furusyo Am J Trop 1999

WHO verification

Decision date: n.a.

85.0%

14.0%

Unknown ₀

20 40 60 80 100

2009 2010 2011 2012 2013

0 20 40 60 80 100

<50% 50%-79% 80%-89% 90%-94% > 94%

% Districts 2013

Hepatitis B Control

Hepatitis B Control

Country Profiles 2013

Hepatitis B Control

Country Profiles 2013

CONTENTS

Regional Progress: Hepatitis B Vaccination Coverage, 1990 – 2013 1 Regional Progress: Status of the 2013 Hepatitis B Control Milestone 2

Country Profiles

American Samoa 3

Australia 4

BruneI Darussalam 5

Cambodia 6

China 7

Hong Kong SAR (China) 8

Macao SAR (China) 9

Cook Islands 10

Fiji 11

French Polynesia 12

Guam 13

Japan 14

Kiribati 15

Lao People’s Democratic Republic 16

Malaysia 17

Marshall Islands 18

Federated States of Micronesia 19

Mongolia 20

Nauru 21

New Caledonia 22

New Zealand 23

Niue 24

Northern Mariana Islands 25

Palau 26

Papua New Guinea 27

Philippines 28

Republic of Korea 29

Samoa 30

Singapore 31

Solomon Islands 32

Tokelau 33

Tonga 34

Tuvalu 35

Vanuatu 36

Viet Nam 37

Wallis and Futuna 38

COUNTRY

COUNTRY

AMERICAN SAMOA

AUSTRALIA

BRUNEI

DARUSSALAM

CAMBODIA

CHINA

HONG KONG SAR (CHINA)

MACAO SAR (CHINA)

COOK ISLANDS

FIJI

FRENCH POLYNESIA

GUAM

JAPAN

KIRIBATI

LAO PEOPLE’S DEMOCRATIC REPUBLIC

MALAYSIA

MARSHALL ISLANDS

FEDERATED STATES OF MICRONESIA

MONGOLIA

NAURU

NEW CALEDONIA

NEW ZEALAND

NIUE

NORTHERN

MARIANA ISLANDS

PALAU

PAPUA NEW GUINEA

PHILIPPINES

REPUBLIC OF KOREA

SAMOA

SINGAPORE

SOLOMON ISLANDS